Luis Jose Catoggio

Luis Jose Catoggio

Auto-generated profile, based on publicly available information

Luis Jose Catoggio

Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires y Fundación Dr Pedro M Catoggio para el Progreso de la Reumatología, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
CLCarl D. Langefeld
Carl D. Langefeld
HAHannah C Ainsworth
Hannah C Ainsworth
DGDeborah S Cunninghame Graham
Deborah S Cunninghame Graham
JKJennifer A Kelly
Jennifer A Kelly
MCMary E Comeau
Mary E Comeau
TVTimothy J Vyse
Timothy J Vyse
Systemic lupus erythematosus (SLE) is an autoimmune disease with marked gender and ethnic disparities. We report a large transancestral association study of SLE using Immunochip genotype data from 27,574 individuals of European (EA), African (AA) and Hispanic Amerindian (HA) ancestry. We identify 58 distinct non-HLA regions in EA, 9 in AA and 16 in HA (∼50% of these regions have multiple independent associations); these include 24 novel SLE regions (P<5 × 10−8), refined association signals in established regions, extended associations to additional ancestries, and a disentangled complex HLA multigenic effect. The risk allele count (genetic load) exhibits an accelerating pattern of SLE risk, leading us to posit a cumulative hit hypothesis for autoimmune disease. Comparing results across the three ancestries identifies both ancestry-dependent and ancestry-independent contributions to SLE risk. Our results are consistent with the unique and complex histories of the populations sampled, and collectively help clarify the genetic architecture and ethnic disparities in SLE.

1 January 2004 in Medicine
Verified
Journal Article
Closed access
BPBernardo A. Pons-Estel
Bernardo A. Pons-Estel
LCLuis J. Catoggio
Luis J. Catoggio
MCMario H. Cardiel
Mario H. Cardiel
ESEnrique R. R. Soriano
Enrique R. R. Soriano
SGSilvana Gentiletti
Silvana Gentiletti
DADonato Alarcón-Segovia
Donato Alarcón-Segovia
Clinical and laboratory manifestations and outcome of systemic lupus erythematosus (SLE) may vary in different populations. A prospective multinational inception cohort should prove useful in identifying the influence of ethnicity on the clinical characteristics of SLE. We therefore analyzed clinical, laboratory, and prognostic variables in Latin American SLE patients with disease of recent onset who were entered into a prospective cohort, and compared these variables in the cohort’s 3 major ethnic groups. Thirty-four centers from 9 Latin American countries participated by randomly incorporating SLE patients within 2 years of diagnosis into a standardized database. Participating centers were selected for their expertise in diagnosing and managing SLE. We were then able to evaluate prospectively socioeconomic variables, ethnicity, type of medical care, clinical and laboratory features, disease activity, damage, and mortality at each site. A coordinating center controlled the quality of the information submitted. Of the 1,214 SLE patients included in the cohort, 537 were mestizos, 507 were white, and 152 were African-Latin American (ALA). (There were also small numbers of pure Amerindian and oriental individuals.) Significant differences were found between them in socioeconomic characteristics, type of care, and level of education favoring whites. Mestizos and ALA were younger at onset. Delay to diagnosis and disease duration was shorter in ALA. Fever was more frequent in whites; discoid lesions in ALA; renal disease and lymphopenia in mestizos and ALA. Although we found differences in background variables between ethnic groups from different countries, mestizos from 2 distant countries (Argentina and Mexico) were clinically akin and showed similar differences to whites. Mortality was associated with lower education, poor medical coverage, and shorter follow-up. In an exploratory model nonwhite ethnicity was associated with renal disease and lymphopenia, damage, and cumulative American College of Rheumatology criteria. These differences in clinical, prognostic, socioeconomic, educational, and access to medical care features in Latin American lupus patients of 3 major ethnic groups from 9 different countries may have an impact on the patients’ disease. “Hispanics,” as they have come to be generically termed on the basis of language, actually constitute a markedly heterogeneous group of subjects.

1 June 2001 in Arthritis & Rheumatism
Verified
Journal Article
Closed access
PDF file
JPJanet E. Pope
Janet E. Pope
NBNicholas Bellamy
Nicholas Bellamy
JSJames R. Seibold
James R. Seibold
MBMurray Baron
Murray Baron
MEMichael Ellman
Michael Ellman
DFDaniel E. Furst
Daniel E. Furst

1 February 1983 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
LCL.J Catoggio
L.J Catoggio
RBR.M Bernstein
R.M Bernstein
CBC.M Black
C.M Black
GHG.R Hughes
G.R Hughes
PMP.J Maddison
P.J Maddison
The relation between clinical and serological findings was studied in 75 patients with definite progressive systemic sclerosis (PSS). Antinuclear antibodies were detected by indirect immunofluorescence in 95% of the patients by means of HEp-2 cells. The centromere pattern was observed in 50% of the patients with calcinosis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactyly, and telangiectasia (CREST) and only 7% of the group with diffuse disease. Precipitating antibodies to nuclear and cytoplasmic antigens were detected by immunodiffusion in 53% of the patients and identified as anti Scl-70 in 16 (21%). We confirmed that autoantibodies are very frequent in PSS but varied in specificity. A combination of immunodiffusion and indirect immunofluorescence was useful in detecting antibodies characteristic of PSS (i.e., anti-Scl-70 and anticentromere) in 51% of these patients. Anticentromere antibody has a high specificity for CREST and identifies patients with less severe disease (i.e., more prolonged course and less involvement of internal organs). Anti-Scl-70 was associated with a high frequency of lung involvement.

1 December 2005 in Lupus
Verified
Journal Article
Closed access
Mercedes GarciaMercedes Garcia
Mercedes Garcia
JMJ C Marcos
J C Marcos
AMA I Marcos
A I Marcos
BPB A Pons-Estel
B A Pons-Estel
DWD Wojdyla
D Wojdyla
DAD Alarcon-Segovia
D Alarcon-Segovia
The objective of the study was to evaluate the influence of the male gender in the clinical presentation and outcome of systemic lupus erythematosus in a prospective inception cohort of Latin-American patients. Of the 1214 SLE patients included in the GLADEL cohort, 123 were male. Demographic characteristics as well as clinical manifestations, laboratory profile, activity and damage scores were evaluated at onset and during the course of the disease and compared with female patients. The median age at onset of the male patients was 27 and that at diagnosis 29.2 years. Delay to diagnosis was shorter in males (134 versus 185 days, P = 0.01). At onset, men more frequently showed fever (42.3 versus 27.0%, P = 0.001) and weight loss (23.6 versus 11.8%, P = 0.001). During disease course the incident of symptoms was: fever, 67.8 versus 55.6%, P = 0.012; weight loss, 47.2 versus 24.3%, P = 0.001; arterial hypertension, 37.4 versus 25.8%, P = 0.007; renal disease (persistent proteinuria and/or cellular casts), 58.5 versus 44.6%, P = 0.004); and hemolytic anemia, 19.5 versus 10.9%, P = 0.008. The laboratory results showed that: men more frequently had IgG anticardiolipin antibodies (68.2 versus 49%, P = 0.02) and low C3 (61.3 versus 48.1%, P = 0.03); 5/123 men died (4%) compared with 29/1091 women (2.7%). In conclusion, 10% of GLADEL’s cohort patients were male. They showed a distinctive profile with shorter delay to diagnosis, higher incidence of fever, weight loss, arterial hypertension, renal disease, hemolytic anemia, IgG anticardiolipin antibodies and low C3. Although not statistically significant, mortality was higher in men.

18 December 2006 in American Journal of Physical Anthropology
Verified
Journal Article
Closed access
PDF file
MSMichael F. Seldin
Michael F. Seldin
CTChao Tian
Chao Tian
RSRussell Shigeta
Russell Shigeta
HSHugo R. Scherbarth
Hugo R. Scherbarth
GSGabriel Silva
Gabriel Silva
MAMarta E. Alarcón-Riquelme
Marta E. Alarcón-Riquelme